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Abstract 
Interactions of monomeric alpha synuclein (αS) with lipid membranes have been suggested to 
play an important role in initiating aggregation of αS. We have systematically analyzed the 
distribution and self-assembly of monomeric αS on supported lipid bilayers (SLBs). We observe 
that at protein to lipid ratios higher than 1:10 αS forms micrometer sized clusters, leading to 
observable membrane defects and decrease in lateral diffusion of both lipids and proteins. An αS 
deletion mutant lacking amino acid residues 71-82 binds to membranes, but does not observably 
affect membrane integrity. Whereas this deletion mutant cannot form amyloid, significant 
amyloid formation is observed in the wild-type αS clusters. These results suggest that the process 
of amyloid formation rather than binding of αS on membranes is crucial in compromising 
membrane integrity. 
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Introduction 
The 14.4 kDa neuronal protein αS is a major component of Lewy bodies, which are a 
pathological hallmark of Parkinson’s disease (PD) (1). Neuronal death has been attributed to 
various causes (2-6), all of which involve the aggregation of αS into amyloid structures. Above a 
critical concentration αS aggregates in vitro into oligomers and fibrils (7), with the details of 
aggregation depending on pH (8), salt (9) and temperature (8) conditions. There is increasing 
evidence that interactions with lipid bilayers play a role in αS aggregation (10, 11), although 
there have been some unresolved debates in earlier literature (12, 13).  
αS-lipid membrane interactions depend on the negative charge on the membrane (12). These 
interactions are mediated by positively charged residues located in seven imperfect repeats in the 
N-terminus of the protein (14, 15). These repeats are reminiscent of lipid membrane binding 
domains in apolipoproteins, with the first five repeats predicted and shown to form alpha helices 
upon binding to negatively charged SUVs (16, 17). 
In vitro, the presence of negatively charged lipid membranes accelerates αS aggregation into 
amyloids (12). For other amyloid forming proteins like Aβ and IAPP, membrane integrity is 
affected by extensive membrane remodeling and lipid extraction (18-23). There is increasing 
evidence that this is also the case for αS (11, 24-27). Further, the report of measurable amounts 
of lipids in Lewy bodies (6) strongly suggests that the interaction of lipid membranes with αS is 
relevant in the aggregation process. 
One of the major reasons attributed to neuronal cell death in PD is membrane damage (28-30). It 
is uncertain if certain oligomeric species or the aggregation process causes the observed 
membrane damage. Moreover, the exact mechanism of this damage remains to be elucidated. 
Both monomers and oligomers of WT-αS have been shown to cause dye leakage in model 
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membrane vesicles, consistent with a pore-like mechanism (31-34). However, this leakage is 
observed only at high surface charge densities indicating that other mechanisms maybe important 
at physiologically relevant charge densities. WT-αS oligomers with a putative channel-like 
structure have been shown to induce single ion-channel currents in lipid membranes (35). Recent 
reports also indicate that addition of monomeric wild type αS (WT-αS) causes membrane 
damage in SLBs (24, 26). Thus, it is unclear whether membrane damage is due to αS amyloid 
formation on the membrane or is a result of binding of αS species to the membrane. To 
distinguish between these two mechanisms for membrane damage, we studied a deletion mutant 
lacking amino acid residues 71-82 (αS(Δ71-82)) that in solution fails to form amyloids but forms 
spherical oligomers with a diameter of ~20nm (36). We used SLBs as a platform to visualize and 
measure the interactions of WT-αS and αS(Δ71-82) with membranes by confocal microscopy 
using fluorescently labeled SLBs and αS. We indirectly modulated the rate of aggregation of αS 
on the membrane surface by varying the negative lipid composition and thereby modulating the 
density of surface-bound protein. The presence of a charged protein on a charged membrane 
surface can influence lateral lipid diffusion and protein-protein interactions. We used 
fluorescence recovery after photobleaching (FRAP) to measure changes in the lateral diffusion 
coefficients of lipids to extract quantitative information about lipid phase and fluidity. FRAP was 
also used to probe diffusion of αS and its aggregation on the SLB surface. We observe that 
formation of amyloids by WT-αS results in lipid extraction and decrease the mobility of lipids in 
SLBs. Neither effect is observed with the deletion mutant even though it binds membranes with 
comparable affinity. 
Materials and methods 
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Stock solutions of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1-palmitoyl,2-
oleoyl phosphatidylglycerol (POPG), and 1-palmitoyl-2-[6-[(7-nitro-2-1,3-benzoxadiazol-4-
yl)amino]hexanoyl]-sn-glycero-3-phosphocholine (NBD-PC) in chloroform were purchased 
from Avanti Polar Lipids (Birmingham, AL) and used without further purification. 
Ethylenediaminetetraacetic acid (EDTA) was purchased from Sigma Chemicals (St. Louis, MO). 
Sodium chloride (NaCl), sodium hydroxide (NaOH), and 4-(2-hydroxyethyl)-1-
piperazineethanessulfonic acid (HEPES) were purchased from Merck (Germany). Alexa Fluor 
647 C2 maleimide and β-BODIPY® FL C5-HPC (2-(4,4-Difluoro-5,7-Dimethyl-4-Bora-3a,4a-
Diaza-s-Indacene-3-Pentanoyl)-1-Hexadecanoyl-sn-Glycero-3-Phosphocholine was purchased 
from Invitrogen (Carlsbad, CA). 
 Substrate Pretreatment 
Glass cover-slips were washed in 2 % Hellmanex (VWR International, Chicago, IL) at 80° C for 
60 minutes, rinsed exhaustively with deionized water and then dried with a stream of nitrogen. 
The slides were etched for 8 minutes in a solution of 3:1 (v/v) concentrated sulfuric acid (H2SO4) 
and 30% hydrogen peroxide (H2O2). The slides were stored in MilliQ water, and were used 
within 3 days after treatment. 
Vesicle and supported lipid bilayer preparation 
Lipid stock solutions of POPC and POPG in chloroform were mixed in 1:1 or 3:1 molar ratios, 
dried under a stream of nitrogen, and placed under vacuum for 1 h. After drying, the lipid films 
were rehydrated in 100 mM NaCl solution. Large unilamellar vesicles (~ 500 µM in lipids) were 
prepared by extruding the solution 21 times through 100 nm polycarbonate membranes. The 
vesicles were stored at 4oC and used within 3 days. Supported lipid bilayers were formed by 
vesicle fusion inside a 120 µL custom built chamber on appropriately treated glass slides. The 
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extruded vesicles were mixed with 750 mM NaCl solution at a 1:1 ratio to induce fusion as 
reported before(37). After 20 min incubation, excess vesicles were removed from the chamber 
by rinsing with a 50 mM HEPES, 0.1 mM EDTA, and 750 mM NaCl, pH 7.4 buffer. Thereafter 
the chamber was rinsed with 50 mM HEPES, 0.1 mM EDTA, pH 7.4 buffer to remove salt. At 
least 3 mL of buffer were passed through the chamber to ensure complete solvent exchange.  
Expression, purification and labeling of αS  
Since WT-αS does not contain any cysteine residues necessary for fluorescent labeling, an 
alanine to cysteine mutation was introduced at residue 140. The WT-αS-A140C mutant was 
expressed in Escherichia coli strain BL21 (DE3) using the pT7-7 expression plasmid and 
purified in the presence of 1 mM DTT as previously reported (38). The cDNAs for the deletion 
mutant of αS lacking 71-82 residues (αS(Δ71-82)) were obtained from Prof. Benoit Giasson 
from University of Florida (USA). The cDNA was cloned into a pT7-7 expression plasmid and 
purified. For labeling αS(Δ71-82), an alanine to cysteine mutation was introduced at residue 140 
as for the WT-αS. Prior to labeling, both WT-αS-A140Cand αS(Δ71-82)-A140C were reduced 
with a five-fold molar excess of DTT for 30 min at room temperature. The samples were 
desalted with Pierce Zeba desalting columns, followed by the addition of a two-fold molar 
excess of Alexa 647 (AL647) C2 maleimide dye (Invitrogen) and incubated for two hours in the 
dark at room temperature. Free label was removed using two desalting steps. The protein 
labeling efficiency was estimated to be 90% from the absorption spectrum. Before use, the 
protein was diluted with 50 mM HEPES, 0.1 mM EDTA, pH 7.4 buffer to the desired 
concentrations. 
Imaging of supported lipid bilayers and proteins 
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All measurements were performed on a Nikon (Tokyo, Japan) A1 confocal microscope equipped 
with a perfect focus system (PFS). SLBs were visualized by incorporating 0.25 mol% BODIPY-
PC. To visualize the proteins, a mixture of 25% labeled and 75% unlabeled protein was used. 
The SLBs were prepared as reported before (37). In a typical experiment, exactly two times the 
chamber volume (~240 µl) of the desired concentrations of the protein was flushed into the 
perfusion chamber with an oil-free pump. The proteins were incubated with the SLBs for 18 
hours at room temperature. Thereafter the unbound protein was washed off with 50 mM HEPES, 
0.1 mM EDTA, pH 7.4 for 10 minutes to remove background fluorescence from the unbound 
protein in the solution. While the washing step could potentially lead to desorption, within the 
time frame of the measurements we see less than 10% decrease in the protein fluorescence from 
these bilayer systems. Images were acquired using a 63X water immersion, 1.30 NA objective 
combined with a 2X optical zoom. The acquired images consisted of 512 × 512 pixels with a 
pixel size of 0.41 × 0.41 μm. All images were collected under identical conditions of power and 
gain. For visualization purposes only, the contrast threshold was set to a constant value, allowing 
comparison of all images. 
Image processing and cluster analysis 
The Nikon NIS Elements ObjectCount module was used for area estimation of αS clusters. Using 
intensity thresholding, areas of αS clusters were calculated automatically from the pixel areas in 
at least 10 images per protein concentration. Since the number of clusters and their sizes depend 
directly on the level of the threshold set, we systematically varied the threshold (Fig. S1 in the 
Supporting Material) to choose an optimum threshold. For each image, the intensity threshold 
was fixed to 1.5 times the peak intensity of its intensity histogram, avoiding under- or over-
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sampling. The cluster area distribution for each protein concentration was fit to a log-normal 
distribution to get an average cluster area (39).  
Fluorescence Recovery After Photobleaching (FRAP) 
FRAP was used to determine the diffusivity of lipids in the bilayer and of the labeled protein on 
the lipid bilayer after incubation. FRAP was performed on a NikonA1 confocal microscope. A 
100-mW Argon ion laser (488 nm, Coherent, CA) was used to both bleach and monitor the lipid 
bilayer fluorescence. A 30-mW laser (647 nm, Coherent, CA) was used to bleach and monitor 
protein fluorescence. In the FRAP experiment, fluorescence from a circular region of interest 
(ROI) was bleached (radius ~12 µm) in 1.5 s. After bleaching, the increase in fluorescence 
intensity in the ROI was monitored for 8 minutes. During the experiment there was only a 
minimal drop in the fluorescence intensity in the reference ROI. All FRAP data were fitted using 
the Soumpasis fit (40) which has been shown to better model membrane/protein diffusivity than 
a single exponential fit (41), yielding the diffusion coefficients and mobile fractions of the 
probed entity. 
Circular dichroism (CD) spectroscopy 
A Jasco J-715 spectropolarimeter was used to obtain CD spectra at protein concentrations of 3 
μM in solution. Spectra were recorded between 190 to 260 nm with a step size of 0.5 nm and a 
scanning speed of 10 nm/min using a 1-mm path length cuvette. The apparent dissociation 
constants (Kdapp) for both proteins were determined by titrating them against POPC:POPG 
(50:50) SUVs and fitting the measured mean residue ellipticity at 222 nm, R, to the solution of 
the binding equilibrium equation: 
R
n
LP ↔+    (1) 
By assuming equilibrium binding and applying the law of mass action, solving for R, we obtain: 
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where R is the measured signal (MRE at 222nm, corrected for dilution) at a given lipid 
concentration, L is the total lipid concentration, and P is the total concentration of the protein. 
Kdapp is the apparent macroscopic dissociation equilibrium constant, and n is the binding 
stoichiometry (lipids/protein). Rf and Ro are the final (corrected for dilution) and initial mean 
residue ellipticities respectively. This equation assumes that all lipid-binding sites are equivalent 
and that Kdapp does not depend on the lipid/protein ratio (42). Since αS adopts a helical 
conformation upon membrane binding (16), titration of WT-αS and αS(Δ71-82) with 
POPC/POPG (1:1) SUVs allows an estimate of Kdapp from the characteristic band at 222 nm. 
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Results 
WT-αS and αS(Δ71-82) bind lipid membranes with comparable affinities 
In order to compare the clustering and possible aggregation of WT-αS and αS(Δ71-82) on lipid 
membranes, the binding of both proteins to SLBs has to be comparable. We used CD 
spectroscopy to measure binding affinities of αS(Δ71-82) and WT-αS to POPC:POPG (1:1) 
SUVs (42) (Materials and Methods). The data (Figure 1) show that the binding affinities of both 
constructs to the lipid bilayer are comparable. Although the WT-αS and αS(Δ71-82) exhibit 
similar binding affinities to lipid membranes, they show different aggregation behavior in 
solution. In absence of membranes, αS(Δ71-82) does not form fibrillar amyloids (36) and 
aggregation arrests at an oligomeric stage (43), whereas WT-αS readily aggregates into cross-β 
sheet rich amyloid structures. Aggregation experiments under our experimental conditions 
confirmed this reported difference in aggregation behavior (Fig. S2 in the Supporting 
Material). 
 
WT-αS and αS(Δ71-82) self-assemble differently on POPC:POPG (1:1) SLBs 
Upon systematically varying the concentration of αS on POPC:POPG (1:1) SLBs, we observed 
that both WT-αS and αS(Δ71-82) organized into clusters on the SLB surface. Although the 
binding affinities of these proteins were comparable, there was a clear difference in the 
organization of these clusters (Figure 2), obtained upon incubation of 10 µM protein on SLBs 
after 18 hours (P/L ratio ~1:1). 
WT-αS assembles into a heterogeneous distribution of clusters of both small and large areas, 
whereas clusters of αS(Δ71-82) are more homogenous in size. Upon decreasing the P/L ratio, we 
observe that assembly of both WT-αS (Fig. S3 in the Supporting Material) and αS(Δ71-82) 
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clusters (Fig. S4 in the Supporting Material) are sensitive to protein concentration, with cluster 
size increasing as a function of protein concentration. In order to obtain a quantitative overview 
of protein cluster size, we estimated average cluster areas (Materials and Methods) by fitting the 
measured area distribution to a log-normal distribution. Figure 3 depicts the correlation between 
the protein concentration and average cluster areas. 
As shown in Figure 3, we obtained αS cluster areas from incubation of WT-αS and αS(Δ71-82) 
on POPC:POPG (75:25) SLBs (Fig. S5 in the Supporting Material). This experiment was done 
to investigate if the percentage of negatively-charged lipids influenced the clustering of αS on 
SLBs. The WT-αS clusters are consistently smaller on less negatively charged SLBs (i.e. 25% 
versus 50% POPG content). The histograms of the cluster areas (Fig. S6 in the Supporting 
Material) show a more heterogeneous distribution (larger widths) for the WT-αS clusters at all 
concentrations. The smallest calculated cluster area using our thresholding parameters is 0.04 
µm2 which corresponds to the pixel area in the image. We cannot make any conclusive 
predictions about the size or aggregation number (number of monomers) of αS structures 
inducing membrane damage. At these high P/L ratios (1:1), it has been previously reported that 
WT-αS forms amyloid structures depending on the percentage of negative charge in the lipid 
membranes (12). Our observations show a charge-dependent increase in the size of WT-clusters 
on SLBs at high P/L ratios. 
In order to establish if the observed WT-αS clusters contain amyloid, SLBs containing 10 µM 
WT-αS clusters were incubated with 50 µM of ThioflavinT (ThT) for one hour. After washing 
off unbound ThT, most of the clusters seen in the protein channel were found to be positive for 
ThT fluorescence (Figure 4), confirming the formation of amyloid aggregates on the SLB 
surface (18, 24). The average intensities in all ThT positive clusters were at least 150 times 
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higher than background intensities. It is interesting to note that not all clusters of WT-αS are 
positive for ThT fluorescence (Figure 4; Panel B).  
To investigate if the clusters of WT-αS can reorganize and grow into bigger amyloid aggregates, 
we incubated the aggregates formed from 10 µM WT-αS after 18 hours on POPC:POPG (1:1) 
SLBs for another 24 hours. As expected for amyloid growth, we observe a marked increase in 
the protein aggregate size as shown in Figure 5. Closer inspection of the WT-αS amyloid 
aggregates in Figure 5 show evidence of lipid fluorescence (arrows in Figure 5). This may be a 
result of lipids being extracted out of the membrane upon amyloid formation. We see fewer 
protein aggregates at this stage which suggests that smaller aggregates fuse into bigger 
structures; however, an alternative explanation could be that the aggregates desorb from the 
membrane.  
Aggregation of αS affects lipid membrane mobility  
Protein aggregation on SLBs requires that the observed clusters are mobile on the bilayer. This 
mobility would be affected by the protein-protein interactions required for aggregation into 
amyloid fibrils. The dependence of protein clustering on lipid composition further suggests that 
there are specific lipid-protein interactions. To characterize the aggregation state of αS, we used 
FRAP to probe the diffusion of WT-αS and αS(Δ71-82) on SLBs. We observed that at 10 µM 
protein concentration the diffusion coefficient of WT-αS (DαS) had a much lower value ( ~ 0.14 
µm2/sec) than that for αS(Δ71-82) (~1.1 µm2/sec) (Figure 6A). The αS(Δ71-82) mutant diffuses 
much faster than the WT-αS at all protein concentrations. We attribute the faster diffusion to 
significantly reduced interactions between αS(Δ71-82) species as compared to that of WT-αS. 
Consistent with strong protein-protein interactions and amyloid formation we observed a 
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decrease (up to 30%) in the mobile fraction of the WT-αS species with increasing concentrations 
of the protein (Figure 6B).   
The mobile fraction of αS(Δ71-82) does not change. We analyzed the average fluorescence 
intensities from the protein channel after incubation of labeled WT-αS and αS(Δ71-82) on 
POPC:POPG SLBs. SLBs incubated with different concentrations of WT-αS showed a linear 
increase in fluorescence intensity whereas SLBs with αS(Δ71-82) did not. Intriguingly, a similar 
trend was observed with WT-αS upon decreasing the percentage of negative lipids in the SLBs 
(Figure 6C). After incubation for 18 hours, the unbound protein was washed off. Since the 
binding affinities of WT-αS and αS(Δ71-82) were comparable, the SLBs should be fully covered 
with αS at all concentrations used. Thus, after the washing step, the fluorescence intensity should 
have been comparable for SLBs incubated with WT-αS and αS(Δ71-82). The fact that we see an 
increase in fluorescence intensity with increasing concentration of WT-αS suggests direct 
adsorption of incoming WT-αS onto attached WT-αS species. A higher intensity could also be a 
result of compaction of existing aggregates into ordered structures, thereby creating space for 
incoming monomers.  
To investigate the effect of αS binding on lateral mobility of lipids in POPC:POPG SLBs, we 
used fluorescent recovery after photo-bleaching (FRAP) using BODIPY-PC as a fluorescent 
lipid probe. The diffusion coefficient of BODIPY-PC in the absence of protein was found to be 
~1.25 µm2/sec, similar to values reported in literature for lateral diffusion of lipids in SLBs on 
glass surfaces (44, 45). The lipids were completely mobile (mobile fraction > 98%) and SLBs 
were found to be stable over an incubation period of at least 42 hours. Increasing concentrations 
of WT-αS (P/L ratios from 0.02 to 1) were incubated on separate SLBs for 18 hours. After 18 
hour incubation with WT-αS, a drop in the diffusion coefficient of BODIPY-PC in SLBs was 
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observed with increasing P/L ratios. At P/L ratios below 0.1, there is little effect on the lipid 
bilayer fluidity, but starting from P/L ~ 0.1, we observe a drop in the diffusion coefficient of 
BODIPY-PC (DB) (Figure 6D). The mobile fraction of BODIPY-PC remained unchanged upon 
incubation of WT-αS and αS(Δ71-82) at all protein concentrations and lipid compositions. DB 
dropped by ~55% and ~30%on 50% POPG and 25% POPG SLBs respectively. Upon incubation 
of similar concentrations of αS(Δ71-82) on POPC:POPG SLBs, we found no change in the 
apparent diffusion coefficients of BODIPY-PC in either lipid composition as seen in Figure 6D. 
The increase in the protein aggregate size coincides with the drop in DB. Thus formation of small 
protein clusters is not enough to decrease the lateral diffusion of lipids, whereas aggregation of 
αS into larger clusters and/or amyloids with typical cross-β sheets is correlated with the 
decreased lateral diffusion of SLBs.  
Amyloid formation and lipid extraction are correlated 
To probe the effects of WT-αS aggregation and αS(Δ71-82) clustering on the integrity of SLBs, 
we systematically varied the concentration of αS on SLBs. 0.25 mol% BODIPY-PC was 
incorporated to visualize the SLBs. In the absence of protein the bilayers were devoid of defects, 
cracks or any other inhomogeneities resolvable by our confocal microscope (Figure 2; Control). 
Upon adding increasing concentrations of WT-αS to separate SLBs, we observe a general loss of 
BODIPY-PC fluorescence intensity and appearance of defects with no lipid present (black 
regions in images) and patterns of elongated cracks with lower than average fluorescence 
intensities, suggesting damage to the SLBs (Figure 2) after 18 hours. 
We observed that the extent of this damage seems to reduce as the protein concentration is 
reduced (P/L ratio from 1 to 0.02) (Fig. S3). In contrast to what was observed with WT-αS, when 
αS(Δ71-82) is added to the SLBs, there was much less evidence of damage to SLBs (Fig. S4). 
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αS(Δ71-82) did however form smaller clusters on the bilayer surface as seen in Figure 2. 
Control experiments involving SLBs incubated in buffer show no such damage over the time 
scale of the experiments. Moreover, these SLBs show negligible loss in BODIPY-PC 
fluorescence intensity over a period of at least 42 hours. The onset of aggregation of WT-αS to 
form amyloid structures is faster with increasing composition of negatively charged lipids (12). 
Accordingly, to probe if amyloid formation was involved in the observed membrane damage, we 
decreased the proportion of negative lipids. Upon incubation of 10 µM protein on POPC:POPG 
(75:25) SLBs for 18 hours, we found that WT-αS causes fewer and smaller defects, whereas 
αS(Δ71-82) mutants show almost no defect formation (Fig. S5). 
We measured the lipid fluorescence in the buffer solution above the SLBs before and after 
incubation with protein for 18 hours. After protein incubation there is a concentration dependent 
increase in lipid fluorescence. This increase is about 3-4 fold larger for WT-αS than for αS(Δ71-
82) (Fig. S7 in the Supporting Material). These results suggest that the general loss of lipid 
fluorescence after incubation with WT-αS could be due to lipid extraction. We suggest that 
formation of amyloid structures in WT-αS occurs concurrently with extraction of lipids from the 
SLBs. 
To test if the loss in membrane fluidity, membrane damage and aggregate formation are 
influenced by the BODIPY probe, SLBs containing a small fraction of NBD-PC lipids were 
incubated with 5 µM and 10 µM WT-αS. Similar defects, cracks in the lipid membrane, and 
protein aggregate formation were observed. We conclude that the specific fluorescent probe does 
not influence our observations. We find the same decrease in DB upon incubation with unlabeled 
protein (5 µM and 10 µM WT-αS) rather than 25% labeled and 75% unlabeled protein, 
confirming that there is no significant effect on DB from adding the fluorophores. 
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Discussion 
WT-αS and αS(Δ71-82) behave differently on SLBs. Collectively, the data presented here shows 
that the adsorption of protein to the membrane surface results in protein clustering. Depending 
on the interactions between proteins, this clustering can result in the formation of amyloid, which 
causes significant perturbations in the bilayer structure and dynamics. 
As the concentration of WT-αS is increased, the lipid structure is altered by formation of defects 
that appear to be devoid of lipid and by formation of a pattern of cracks with fewer lipids. 
Concurrently, the rate of diffusion of the lipid decreases, suggesting that diffusion is either 
hindered by the formation of cracks or slowed down by a strong association of lipid with protein 
clusters. As the concentration of αS(Δ71-82) mutant is increased, there are a few defects but 
there is no evidence of other perturbations to the lipid membranes. We see no cracks and DB is 
unaffected. There is also minimal loss of lipid. The perturbations by the WT-αS on the SLBs 
become more severe as the time of incubation is increased from 18 hours to 42 hours. It is also 
important to note that there are no defects or lipid loss in samples without protein even after 42 
hours. 
The effects of the WT-αS on the membrane fluidity and integrity are generally lipid composition 
dependent and more pronounced at high fractions of negatively charged lipids (POPG). 
Changing the composition of the lipid does not change the effects of the αS(Δ71-82) mutant on 
these membrane properties. Both WT-αS and αS(Δ71-82) are expected to adsorb on the 
membrane in comparable amounts owing to their comparable membrane binding. However, as 
the protein concentration is increased the amount of adsorbed WT-αS increases linearly whereas 
there is no change in the amount of adsorbed αS(Δ71-82) mutant . Interestingly, the adsorption 
of the αS(Δ71-82) mutant is lower on membranes with lower proportion of charged lipids, 
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whereas that of the WT-αS is not. This is consistent with the additional adsorption of the WT-αS 
arising from protein-protein binding rather than protein-lipid binding. 
Both the WT-αS and αS(Δ71-82) mutant appear to form small clusters of protein on the surface. 
As the concentration increases, the average area of these clusters increase by about a factor of 
two. At all concentrations the average cluster area of the WT-αS is larger on the highly charged 
membranes. This agrees with the earlier observations that at high protein-to-lipid ratios, a high 
percentage of negative lipids increases the rate of aggregation of WT-αS (12). Moreover, WT-αS 
is seen to form very large clusters of protein at high concentrations and longer incubation times. 
These large clusters are stained positively by ThT, supporting the conclusion that the proteins in 
the clusters tend to aggregate into amyloid fibrils. Such large ThT positive structures are not 
observed for the deletion mutant. The largest amount of membrane damage occurs when amyloid 
structures form. Therefore, the most likely explanation for the observed membrane damage 
would be the aggregation of WT-αS into amyloids characterized by a significant cross-β sheet 
component on the membrane surface. The evidence for the extent of membrane damage is 
indirect, but support the conclusion that both lipid leaflets are removed since the fluorescence in 
these regions is reduced to background levels.  In the cracks, the fluorescence is reduced, but not 
to the background levels, so these perturbations may be limited to the top leaflet. Defects in the 
SLBs are seen starting from P/L ratios of 1:10 and increase in frequency with higher 
concentrations. Vesicle permeabilization assays showed hardly any dye efflux with POPC:POPG 
LUVs (34), motivating us to test an alternative mechanism. Our data is consistent with a 
mechanism of membrane damage including lipid extraction and incorporation in amyloid 
structures.  
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Prior reports also suggest that αS mutants having higher aggregation propensity cause 
significantly greater membrane damage in SLBs (24) or increased cell death of dopaminergic 
neurons in a rat model (46). Thus aggregation into amyloids is likely to be the prerequisite for 
membrane damage. Previous studies on interaction of WT-αS with POPC:POPS (1:1) (17) and 
POPC:POPA (1:1) (12) supported lipid bilayers using atomic force microscopy (AFM) also 
reveal defects and membrane disruption with formation of protein aggregates on the bilayer 
surface. Recent studies with model vesicles suggest a membrane thinning mechanism (47). WT-
αS has previously been shown to cause phase separation and protein clustering to eggPG rich 
domains (37, 48) in eggPC: eggPG (50:50) SLBs. In our experiments, we do not observe phase 
separation upon addition of WT-αS; this may be attributed to the choice of lipids. Aggregate 
sizes similar to those observed for αS have also observed for β-amyloid (1–40) on POPC/POPG 
SLBs (49). 
The rate of diffusion of the WT-αS is lower than that of the αS(Δ71-82) mutant at all 
concentrations and for both lipid compositions. While the WT-αS diffusion decreases at higher 
concentrations, that of the αS(Δ71-82) mutant does not. Correspondingly, the fraction of mobile 
WT-αS decreases at high concentrations while the αS(Δ71-82) mutant remains fully mobile. The 
decrease in mobile fraction of WT-αS is consistent with the formation of large amyloid 
aggregates and to the change in the lipid diffusion, suggesting a correlation between the two 
effects.  
The diffusivity of the WT-αS is independent of the lipid composition of the SLBs. However, the 
αS(Δ71-82) mutant moves significantly faster on the less charged membrane. This may be 
related to the observation that there is less protein adsorbed, which would suggest that the protein 
diffusion is sensitive to protein concentration on the surface. Since there appears to be no 
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difference in the average cluster area for the αS(Δ71-82) mutant on two differently charged 
membranes, the difference in protein diffusion is not related to the cluster sizes.  
If the changes in lipid and protein diffusion are linked, it could arise from direct protein-lipid 
bilayer interactions. This notion is supported by the observation that the large aggregates co-
localize with lipids. The diffusion of the lipid DB is therefore retarded by the diffusion of the 
protein DαS in proportion to the amount bound to the protein as shown in equation 3 
faSaB DfDfD )1( −+= α    (3) 
Where Df is the measured diffusion coefficient of BODIPY-PC in absence of any protein and fa 
is the fraction of lipid bound. This relation assumes a rapid exchange between free and bound 
lipid on the time scale of the recovery of fluorescence (minutes). Table 1 shows the calculated 
fractions (fa) as a function of protein concentration. fa increases with protein concentration and 
with the fraction of negatively-charged lipids in the SLBs in a self-consistent manner. Although 
BODIPY-PC exhibits reduced lateral mobility upon incubation with WT-αS, its mobile fraction 
remains close to unity at all protein concentrations used. This suggests that BODIPY-PC is not 
immobilized beneath or around the clusters. Thus the lipids in the SLBs must be able to 
exchange within the time scale of the measurement of fluorescence recovery. 
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Table 1: Cluster associated fractions of BODIPY-PC on POPC:POPG SLBs. The table 
below shows clusters associated fraction fa obtained from equation 3. This fraction increases with 
the protein concentration and fraction of negative lipids. Note: the protein diffusion 
measurements at 200 nM had poor signal to background and therefore much poorer fits to the 
recovery curves and greater variability in both diffusion coefficients (DαS) and mobile fractions 
estimates. The error bars indicate standard deviations from 5 independent measurements. 
 Protein 
Concentration (µM) 
Measured DB 
(µm2/sec) 
Measured DαS 
(µm2/sec) 
fa (from 
model) 
WT-αS on 
POPC:POPG 
(50:50) SLBs 
10 0.75 ± 0.07 0.15 ± 0.02 0.39 ± 0.06 
5 0.81 ± 0.06 0.36 ± 0.09 0.42 ± 0.06 
2.5 0.87 ± 0.09 0.37 ± 0.07 0.33 ± 0.07 
1.25 1.08 ± 0.05 0.49 ± 0.10 0.11 ± 0.04 
0.20 1.14 ± 0.03 0.48 ± 0.07 0.05 ± 0.03 
WT-αS on 
POPC:POPG 
(75:25) SLBs 
10 0.84 ± 0.04 0.12 ± 0.01 0.31 ± 0.02 
5 1.04 ± 0.06 0.25 ± 0.07 0.18 ± 0.03 
2.5 1.10 ± 0.10 0.29 ± 0.05 0.12 ± 0.04 
1.25 1.08 ± 0.09 0.35 ± 0.05 0.09 ± 0.04 
0.20 0.97 ± 0.06 0.57 ± 0.15 0.14 ± 0.11 
αS(Δ71-82) on 
POPC:POPG 
(50:50) SLBs 
10 1.05 ± 0.04 0.62 ± 0.08 0.05 ± 0.03 
5 1.02 ± 0.04 0.56 ± 0.11 0.06 ± 0.02 
2.5 1.13 ± 0.09 0.60 ± 0.05 0.04 ± 0.01 
1.25 1.04 ± 0.05 0.63 ± 0.15 0.04 ± 0.02 
0.20 1.02 ± 0.07 0.84 ± 0.47 0.10 ± 0.05 
αS(Δ71-82) on 
POPC:POPG 
(75:25) SLBs 
10 1.21 ± 0.06 1.16 ± 0.08  0.08 ± 0.03 
5 1.21 ± 0.07 1.16 ± 0.10 0.08 ± 0.05 
2.5 1.49 ± 0.02 1.02 ± 0.12 0.04 ± 0.01 
1.25 1.42 ± 0.05 0.98 ± 0.16 0.03 ± 0.02 
0.20 1.09 ± 0.08 0.78 ± 0.17 0.06 ± 0.04 
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A model for aggregation of αS on SLBs. 
Our operating model for the action of αS on SLBs is illustrated in Figure 7. αS initially binds the 
charged lipids in the membranes via a conformational change that involves the formation of 
amphipathic alpha helical structures. These adsorbed proteins interact to form small clusters 
which is the end point for the self-assembly of the αS(Δ71-82) mutant. However, in the WT-αS, 
clustering is followed by aggregation allowing additional adsorption of the protein, and leading 
to amyloid-containing protein aggregates. These aggregates bind strongly to negatively-charged 
lipids (POPG), thereby reducing the effective mobility of the lipid mixture. The clusters weakly 
associate with POPC since the mobile fraction of BODIPY-PC is unchanged. If the protein 
aggregate detaches from the membrane it would lead to lipid loss.  
Conclusions 
We report that aggregation of WT-αS on lipid membranes leads to formation of amyloid 
structures which grow in time. This conversion of monomeric WT-αS to amyloid structures 
composed of lipids and WT-αS, is accompanied by significant membrane damage, lipid 
extraction, and reduced lateral mobility of lipids in SLBs. This happens more prominently at 
high protein to lipid ratios. The αS(Δ71-82) mutant fails to form amyloids on the bilayer surface 
and thus is not able to damage lipid membranes. Overall, our data suggests that aggregation of 
WT-αS on lipid membranes affects membrane integrity. Whether the membrane damage 
observed in our experiments arises from a distinct amyloid species or the process of amyloid 
formation remains to be established. 
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Figure Legends 
 
Figure 1: Binding of WT-αS and αS(Δ71-82)with POPC:POPG liposomes. Titration of WT-
αS (red squares) and αS(Δ71-82) (blue circles) by POPC:POPG (50:50) SUVs. The bound 
fractions were obtained by measuring mean residual ellipticites at 222nm by CD spectroscopy 
(Materials and Methods). The binding curve was generated by fitting normalized ellipticity 
values to Equation 2 (solid lines), assuming equivalent binding sites. The error bars indicate 
standard deviations from three independent measurements. 
Figure 2: Clustering of WT-αS and αS(Δ71-82) on POPC:POPG supported lipid bilayers. 
Representative images of SLBs after adsorption of 10 µM αS for 18 hours. The protein images 
show bigger and more heterogeneous WT-αS protein aggregates on 50% POPG-containing 
bilayers as compared to those of αS(Δ71-82) mutant. There appears to be little correlation 
between the defects on the SLBs and the bigger aggregates. The lipid images show the 
appearance of cracks and defects in the top panels (WT-αS). The insert shows these at an 
enhanced magnification. The sparse lipid clustering (seen as bright spots) was also seen in the 
controls and αS(Δ71-82) aggregates do not seem to have a preference for these regions. Fewer 
and smaller defects appear in the presence of αS(Δ71-82) and the average intensity remains the 
same. Images are contrasted to the same extent to facilitate comparison. All experiments were 
performed at room temperature in 50 mM HEPES, pH 7.4, 0.1 mM EDTA buffer. The scale bar 
is 10 µm. 
Figure 3: Average cluster areas of αS on SLBs with changing protein concentration and 
lipid composition. Average cluster areas obtained by fitting the area distributions obtained from 
αS aggregates on POPC:POPG SLBs. Upon increasing protein concentration, there is a two-fold 
increase in the average cluster areas irrespective of the lipid composition for both WT-αS and 
αS(Δ71-82). However, for a given protein concentration, αS(Δ71-82) clusters (red symbols) 
show little dependence on lipid composition contrary to that observed for the WT-αS clusters 
(black symbols). The clusters areas for WT-αS and αS(Δ71-82) on 50% POPG SLBs are shown 
by squares and as triangles for 25% POPG SLBs. The error bars indicate standard errors in each 
case. The statistics underlying the values presented here are shown in Table S1 in the 
Supporting Material. 
Figure 4: ThioflavinT (ThT) staining of WT-αS aggregates. Representative fluorescence 
images depicting the lipid channel (A) and protein channel (B) after 18 hr incubation of 10 µM 
labeled WT-αS on POPC:POPG SLB. The white arrows show aggregates of WT-αS which are 
not positive for ThT. (C) Fluorescence images taken after ThT staining. (D) Overlay of all 
channels. Lipid composition of the bilayer was POPC/POPG/BODIPY-PC, 50:49.75:0.25 
(mol/mol). All images were taken at room temperature in 50 mM HEPES, 0.1 mM EDTA, pH 
7.4 buffer. The scale bar is 10 µm. 
 
Figure 5: Time dependent growth of WT-αS aggregates on POPC: POPG (50:50) SLBs. 
The images shown are representative endpoint images obtained after incubation of 10 µM WT-
αS on POPC:POPG (50:50) after 18 hours (top panel) and the same bilayer incubated for another 
24 hours (bottom panel). Upon incubation for 18 hours, large aggregates are seen on the bilayer 
surface but these aggregates do not coincide with regions of high membrane damage. After 42 
hours, very large aggregates appear that in some regions appear to incorporate lipids. The black 
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arrows show lipids lining along the shape of the aggregate suggesting incorporation. Images are 
contrasted to the same extent to facilitate proper comparison. All experiments were performed at 
room temperature in 50 mM HEPES, pH 7.4, 0.1 mM EDTA buffer. The scale bar is 10 µm. 
 
Figure 6: Effects of adsorption of αS on lipid and protein dynamics of the SLBs. In all the 
figures, measurements with WT-αS are shown with black symbols, those with αS(Δ71-82) with 
red symbols; measurements on 50% POPG-containing membranes are shown with square 
symbols and those on 25% POPG-containing membranes with triangular symbols. A) Apparent 
protein diffusion coefficients (DαS). B) Mobile fractions in protein channel obtained from FRAP 
upon incubation of αS WT-αS and αS(Δ71-82) on POPC:POPG SLBs in increasing 
concentrations. C) Average intensities (normalized to background of red channel) obtained from 
protein channels after 18 hour incubation and removal of unbound protein. The WT-αS clearly 
shows a concentration dependent rise in adsorbed protein irrespective of % of negative charge on 
SLBs, whereas αS(Δ71-82) intensities do not change with concentration. D) Protein 
concentration dependent changes in lateral diffusion coefficients of BODIPY-PC (DB) relative to 
that in the absence of protein. The error bars indicate standard deviation obtained from five 
independent measurements in A), B), and C) and from ten independent measurements in D). All 
experiments were performed at room temperature in 50 mM HEPES, pH 7.4, 0.1 mM EDTA 
buffer. Note: the protein diffusion measurements (B and C) at 200 nM had poor signal to 
background and therefore much poorer fits to the recovery curves and greater variability in both 
diffusion coefficient and mobile fractions estimates. 
Figure 7 : Model for lipid membrane disruption by alpha synuclein. 
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